Extensive meta-analysis of 79 RCTs that included 112,059 participants with and without CVD. After performing 283 sub-analyses, the authors concluded that EPA and DHA supplementation have no effect on CV health. A pity that the results of the recently finished VITAL study were not included. In this NHLB-funded study on 25,871 participants and 5-year follow-up, omega-3 fatty acid supplementation did reduce myocardial infarction by 28%.

Internal Medicine

It is good to see this study. Although most practitioners know this, some may need more studies before they change their practice. Since it is so well known that Omega3 fatty acids decrease cardiovascular mortality and events, it will take more studies like this to also change public perception.